Composition, form of production and packaging
? Capsules soft gelatinous, oval, with opaque two-tone red-black sheath; the contents of the capsules are a greenish-brown liquid with a characteristic odor.
alcoholic extract of the fruits of palm sabal (9-11: 1) 320 mg
Excipients: gelatin succinylated, glycerol, purified water, titanium dioxide, iron oxide black, dye Ponso 4R.
15 pcs. - blisters (1) - packs of cardboard.
15 pcs. - blisters (2) - packs of cardboard.
15 pcs. - blisters (4) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2008.
Phytopreparation, used in functional disorders of urination associated with benign prostatic hyperplasia.
Inhibits the synthesis of dihydrotestosterone (due to blockade of 5-alpha reductase type I and II) and its fixation to cytosolic receptors, which prevents the penetration of the hormone into the nucleus and leads to a decrease in protein synthesis. Reduces the formation of dihydrotestosterone and phospholipase A2 and the release of arachidonic acid, reduces the synthesis of prostaglandins, which regulate the tone and peristalsis of the lower parts of the urinary tract. Has vasoprotective and anti-inflammatory effect, reduces vascular permeability.
Antiandrogenic and vasoprotective actions contribute to reducing symptoms of benign prostatic hypertrophy.
The action of the drug Prostamol Uno is the combined action of the components of the extract of the fruits of Sabalis serrulatae, therefore it is not possible to carry out kinetic studies.
- functional disorders of urination caused by benign prostatic hyperplasia of the I and II stages;
- to eliminate the symptoms of dysuria (urination disorder, night pollakiuria, pain syndrome) with chronic prostatitis (as part of complex therapy).
The drug is prescribed for 320 mg (1 capsule) 1 time / day. The duration of the course of treatment is determined by the doctor.
Capsules should be taken at the same time of the day, after eating, without chewing, with a small amount of liquid.
Possible: allergic reactions.
In rare cases: pain in the stomach, nausea.
- Hypersensitivity to the components of the drug.
The drug reduces the severity of symptoms caused by prostatic hyperplasia, without reducing its size.
At present, cases of overdose of Prostamol Uno were not reported.
At present, no cases of clinically significant drug interaction between Prostamol Uno have been reported.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored in a dark place at a temperature of no higher than 25 В° C. Shelf life - 3 years.